AZAB MOHAMMAD 4
4 · Xenon Pharmaceuticals Inc. · Filed Dec 13, 2022
Insider Transaction Report
Form 4
AZAB MOHAMMAD
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2022-12-12−3,086→ 0 totalExercise: $2.68Exp: 2022-12-31→ Common Shares (3,086 underlying) - Exercise/Conversion
Common Shares
2022-12-12$2.68/sh+3,086$8,270→ 69,905 total
Footnotes (2)
- [F1]The exercise price was converted to U.S. dollars from $2.67 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.
- [F2]The shares subject to the option are fully vested and exercisable.